Dr. James L. Mulshine, M.D., is the Vice President and Associate Provost of Research at Rush University Medical Center in Chicago, Illinois. Dr. Mulshine was previously at the National Cancer Institute (NCI) for 25 years, where he was on the research faculty. While at the NCI, he served as head of the Intervention Section, chair of the lung cancer and chemoprevention faculty and chair of the Institutional Review Board. He was also the NCI representative to the Technology Transfer Review subcommittee for the Director of the National Institutes of Health.

Dr. Mulshine is the primary academic officer responsible managing research activities at Rush University Medical School. Internationally recognized as an expert on lung cancer, At Rush, Dr. Mulshine’s research will concentrate on management of early diseases as a key to success in improving outcomes with lung cancer. He has been awarded 12 patents and has over 280 scientific and medical publications. Dr. Mulshine received his BA from the College of the Holy Cross, and his medical degree from Loyola University Chicago’s Stritch School of Medicine. He completed his residency in internal medicine at the Cleveland Clinic Foundation before moving to the NCI in 1980 where he completed clinical and research fellowships in medical oncology and then joined the faculty. Committed to continuing medical education, Dr. Mulshine is on numerous editorial boards and sits on national and international scientific and foundation advisory boards. He was recognized for lifetime contributions to lung cancer prevention by the International Association for the Study of Lung Cancer.